Tirzepatide

Tirzepatide Tirzepatide is a dual GLP-1 and GIP receptor agonist that has become a central focus of metabolic research over the past several years. GLP-1 and GIP are incretin hormones that play key roles in insulin secretion and glucose regulation. Tirzepatide's ability to target both simultaneously has distinguished it from earlier single-agonist compounds and driven a growing body of research into its effects on glucose homeostasis, pancreatic beta cell function, and adipose tissue regulation. Its dual mechanism continues to drive investigation into incretin-based research pathways and remains one of the most referenced peptides in current endocrine science.